Chemoinformaics analysis of PELARGONIDIN 3-GLUCOSIDE
| Molecular Weight | 433.389 | nRot | 4 |
| Heavy Atom Molecular Weight | 412.221 | nRig | 23 |
| Exact Molecular Weight | 433.113 | nRing | 4 |
| Solubility: LogS | -3.545 | nHRing | 2 |
| Solubility: LogP | 0.579 | No. of Aliphatic Rings | 1 |
| Acid Count | 0 | No. of Aromatic Rings | 3 |
| Base Count | 1 | No. of Aliphatic Carbocycles Rings | 0 |
| Atoms Count | 52 | No. of Aliphatic Hetero Cycles | 1 |
| No. of Heavy Atom | 31 | No. of Aromatic Carbocycles | 2 |
| nHetero | 10 | No. of Aromatic Hetero Cycles | 1 |
| nBridge Head | 0 | No. Saturated Carbocycles | 0 |
| No. of Hydrogen atom | 21 | No. of Saturated Hetero Cycles | 1 |
| No. of Carbon atom | 21 | No. of Saturated Rings | 1 |
| No. of Nitrogen atom | 0 | No. of Arom Atom | 16 |
| No. of Oxygen atom | 10 | No. of Arom Bond | 17 |
| nHA | 9 | APOL | 57.0927 |
| nHD | 7 | BPOL | 26.2753 |
| QED | 0.29 |
| Synth | 4.139 |
| Natural Product Likeliness | 2.003 |
| NR-PPAR-gamma | 0.84 |
| Lipinski | Accepted |
| Pfizer | Accepted |
| GSK | Rejected |
| Golden Triangle | Accepted |
| Pgp-inh | 0.002 |
| Pgp-sub | 0.673 |
| HIA | 0.723 |
| CACO-2 | -6.196 |
| MDCK | 0.0000112 |
| BBB | 0.156 |
| PPB | 0.89617 |
| VDSS | 0.986 |
| FU | 0.135823 |
| CYP1A2-inh | 0.096 |
| CYP1A2-sub | 0.044 |
| CYP2c19-inh | 0.013 |
| CYP2c19-sub | 0.059 |
| CYP2c9-inh | 0.002 |
| CYP2c9-sub | 0.389 |
| CYP2d6-inh | 0.056 |
| CYP2d6-sub | 0.217 |
| CYP3a4-inh | 0.012 |
| CYP3a4-sub | 0.019 |
| CL | 7.971 |
| T12 | 0.748 |
| hERG | 0.013 |
| Ames | 0.713 |
| ROA | 0.142 |
| SkinSen | 0.064 |
| Carcinogencity | 0.298 |
| EI | 0.02 |
| Respiratory | 0.036 |
| NR-Aromatase | 0.948 |
| Antiviral | Yes |
| Prediction | 0.846615 |